|
Summary Information: Soleno Therapeutics Inc. Common Stock NASDAQ:SLNO |
  admin@troach.net |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company's lead candidate, Diazoxide Choline Controlled-Release (DCCR) tablets, a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is currently being evaluated in a Phase III clinical development program.
__The following are links to various summary and news pages for __Soleno Therapeutics Inc. Common Stock [ SLNO ]. __Note: Some Links might not have information for the company. |
|